Published in Eur J Biochem on April 10, 1991
IL-17s adopt a cystine knot fold: structure and activity of a novel cytokine, IL-17F, and implications for receptor binding. EMBO J (2001) 2.84
Triggering cell death: the crystal structure of Apo2L/TRAIL in a complex with death receptor 5. Mol Cell (1999) 2.42
Kringle 5 of plasminogen is a novel inhibitor of endothelial cell growth. J Biol Chem (1997) 1.68
Generation of a humanized, high affinity anti-tissue factor antibody for use as a novel antithrombotic therapeutic. Thromb Haemost (2001) 1.64
Kringle domains of human angiostatin. Characterization of the anti-proliferative activity on endothelial cells. J Biol Chem (1996) 1.63
Siderochromes from Pseudomonas fluorescens. I. Isolation and characterization. J Biol Chem (1982) 1.59
High level Escherichia coli expression and production of a bivalent humanized antibody fragment. Biotechnology (N Y) (1992) 1.43
Structural analysis of BAG1 cochaperone and its interactions with Hsc70 heat shock protein. Nat Struct Biol (2001) 1.43
A unique zinc-binding site revealed by a high-resolution X-ray structure of homotrimeric Apo2L/TRAIL. Biochemistry (2000) 1.34
Siderochromes from Pseudomonas fluorescens. II. Structural homology as revealed by NMR spectroscopy. J Biol Chem (1982) 1.30
Solution conformation of ferrichrome, a microbial iron transport cyclohexapeptide, as deduced by high resolution proton magnetic resonance. J Mol Biol (1970) 1.29
Crystallization and stoichiometry of binding of a complex between a rat intestinal Fc receptor and Fc. J Mol Biol (1993) 1.22
Solution structure of the E-domain of staphylococcal protein A. Biochemistry (1996) 1.12
Proton magnetic resonance study of crambin, a hyperstable hydrophobic protein, at 250 and 600 MHz. Biochemistry (1980) 1.10
ABACUS, a direct method for protein NMR structure computation via assembly of fragments. Proteins (2005) 1.10
Structure of the extracellular domain of human tissue factor: location of the factor VIIa binding site. Biochemistry (1994) 1.08
Effect of metal binding on the conformation of enterobactin. A proton and carbon-13 nuclear magnetic resonance study. Biochemistry (1973) 1.08
Characterization of kringle domains of angiostatin as antagonists of endothelial cell migration, an important process in angiogenesis. FASEB J (1998) 1.05
Equilibrium and kinetic measurements of the conformational transition of reduced thioredoxin. Biochemistry (1987) 1.05
Structural and mutational analysis of affinity-inert contact residues at the growth hormone-receptor interface. Biochemistry (1996) 1.04
Hinge bending within the cytokine receptor superfamily revealed by the 2.4 A crystal structure of the extracellular domain of rabbit tissue factor. Protein Sci (1998) 1.00
The second type II module from human matrix metalloproteinase 2: structure, function and dynamics. Structure (1999) 1.00
The tissue factor region that interacts with substrates factor IX and Factor X. Biochemistry (2000) 0.99
Solution structure and dynamics of the plasminogen kringle 2-AMCHA complex: 3(1)-helix in homologous domains. Biochemistry (1999) 0.99
The 1.85 A resolution crystal structures of tissue factor in complex with humanized Fab D3h44 and of free humanized Fab D3h44: revisiting the solvation of antigen combining sites. J Mol Biol (2001) 0.97
Antibody variable region binding by Staphylococcal protein A: thermodynamic analysis and location of the Fv binding site on E-domain. Protein Sci (1999) 0.97
Tween protects recombinant human growth hormone against agitation-induced damage via hydrophobic interactions. J Pharm Sci (1998) 0.97
Fab assembly and enrichment in a monovalent phage display system. Biotechnology (N Y) (1991) 0.96
Gelatin-binding region of human matrix metalloproteinase-2: solution structure, dynamics, and function of the COL-23 two-domain construct. J Biol Chem (2001) 0.96
Conformational transitions of thioredoxin in guanidine hydrochloride. Biochemistry (1984) 0.95
Lysine/fibrin binding sites of kringles modeled after the structure of kringle 1 of prothrombin. Proteins (1988) 0.93
Domain organization of the 39-kDa receptor-associated protein. J Biol Chem (1999) 0.93
The solution conformation of the ferrichromes. V. The hydrogen exchange kinetics of ferrichrome analogues; the conformational state of the peptides. J Biol Chem (1973) 0.93
Ligand interactions with the kringle 5 domain of plasminogen. A study by 1H NMR spectroscopy. J Biol Chem (1990) 0.92
Nitrogen-15 nuclear magnetic resonance spectrum of alumichrome. Detection by a double resonance Fourier transform technique. J Am Chem Soc (1976) 0.91
Heparin binding to the urokinase kringle domain. Biochemistry (1992) 0.90
Amide proton spin-lattice relaxation in polypeptides. A field-dependence study of the proton and nitrogen dipolar interactions in alumichrome. Biophys J (1978) 0.90
The tissue factor region that interacts with factor Xa in the activation of factor VII. Biochemistry (2001) 0.90
The two polypeptide chains in fibronectin are joined in antiparallel fashion: NMR structural characterization. Biochemistry (1992) 0.89
Epitope location on tissue factor determines the anticoagulant potency of monoclonal anti-tissue factor antibodies. Thromb Haemost (2000) 0.89
Selective inhibition by kringle 5 of human plasminogen on endothelial cell migration, an important process in angiogenesis. Biochem Biophys Res Commun (1998) 0.88
Purification and characterization of tissue plasminogen activator kringle-2 domain expressed in Escherichia coli. Biochemistry (1989) 0.88
Refined solution structure and ligand-binding properties of PDC-109 domain b. A collagen-binding type II domain. J Mol Biol (1992) 0.87
Effects of guanidine hydrochloride on the refolding kinetics of denatured thioredoxin. Biochemistry (1986) 0.87
Origin of fibronectin type II (FN2) modules: structural analyses of distantly-related members of the kringle family idey the kringle domain of neurotrypsin as a potential link between FN2 domains and kringles. Protein Sci (2001) 0.87
Protonated amino acid precursor studies on rhodotorulic acid biosynthesis in deuterium oxide media. Biochemistry (1972) 0.87
Crystal structure of the kringle 2 domain of tissue plasminogen activator at 2.4-A resolution. Biochemistry (1992) 0.86
Solution structure of the tissue-type plasminogen activator kringle 2 domain complexed to 6-aminohexanoic acid an antifibrinolytic drug. J Mol Biol (1991) 0.86
Ligand preferences of kringle 2 and homologous domains of human plasminogen: canvassing weak, intermediate, and high-affinity binding sites by 1H-NMR. Biochemistry (1997) 0.85
Identification of a GDP-L-fucose:polypeptide fucosyltransferase and enzymatic addition of O-linked fucose to EGF domains. Glycobiology (1996) 0.84
A carbon-13 spin lattice relaxation study of alumichrome at 25.1 MHz and 90.5 MHz. Biochim Biophys Acta (1977) 0.84
Sequence-specific 1H NMR assignments and structural characterization of bovine seminal fluid protein PDC-109 domain b. Biochemistry (1991) 0.84
15N nuclear magnetic resonance of living cells. Nature (1975) 0.84
Kringle solution structures via NMR: two-dimensional 1H-NMR analysis of horse plasminogen kringle 4. Chem Phys Lipids (1994) 0.83
Ligand binding to the tissue-type plasminogen activator kringle 2 domain: structural characterization by 1H-NMR. Biochemistry (1995) 0.83
Solution conformation of the ferrichromes. A comparative proton magnetic resonance study of glycine- and serine-containing ferrichromes. J Mol Biol (1972) 0.83
Isolation, purification and 1H-NMR characterization of a kringle 5 domain fragment from human plasminogen. Biochim Biophys Acta (1987) 0.83
The structure of two alanine containing ferrichromes: sequence determination by proton magnetic resonance. Biophys Struct Mech (1976) 0.82
Construction, expression, and purification of recombinant kringle 1 of human plasminogen and analysis of its interaction with omega-amino acids. Biochemistry (1991) 0.82
Solution structure of the epsilon-aminohexanoic acid complex of human plasminogen kringle 1. Eur J Biochem (1994) 0.82
Ligand specificity of human plasminogen kringle 4. Biochemistry (1991) 0.82
Factor VIIa's first epidermal growth factor-like domain's role in catalytic activity. Biochemistry (1999) 0.82
Peptide hydrogen bonding. Conformation dependence of the carbonyl carbon-13 nuclear magnetic resonance chemical shifts in ferrichrome. A study by 13C-[15N] Fourier double resonance spectroscopy1a. J Am Chem Soc (1977) 0.82
Complete assignment of the aromatic proton magnetic resonance spectrum of the kringle 1 domain from human plasminogen: structure of the ligand-binding site. Biochemistry (1987) 0.81
Tissue-type plasminogen activator domain-deletion mutant BM 06.022: modular stability, inhibitor binding, and activation cleavage. Biochemistry (1994) 0.81
The effect of O-fucosylation on the first EGF-like domain from human blood coagulation factor VII. Biochemistry (1999) 0.81
Recombinant gene expression and 1H NMR characteristics of the kringle (2 + 3) supermodule: spectroscopic/functional individuality of plasminogen kringle domains. Biochemistry (1996) 0.81
A nitrogen-15 spin-lattice relaxation study of alumichrome. Biochim Biophys Acta (1978) 0.81
Peptide strain. Conformation dependence of the carbon-13 nuclear magnetic resonance chemical shifts in the ferrichromes. J Am Chem Soc (1977) 0.81
The solution conformation of the ferrichromes. IV. pH dependence of the individual slow amide hydrogen-deuterium exchange in alumichrome. J Biol Chem (1973) 0.80
Exploring functional genomics for drug target and therapeutics discovery in Plasmodia. Acta Trop (2007) 0.80
Proton Overhauser experiments on kringle 4 from human plasminogen. Implications for the structure of the kringles' hydrophobic core. Biochim Biophys Acta (1985) 0.79
1H NMR studies of aliphatic ligand binding to human plasminogen kringle 4. Biochemistry (1989) 0.79
Proton magnetic resonance study of lysine-binding to the kringle 4 domain of human plasminogen. The structure of the binding site. J Mol Biol (1987) 0.79
Solution structure of the kringle domain from urokinase-type plasminogen activator. J Mol Biol (1994) 0.79
Proton magnetic resonance characterization of phoratoxins and homologous proteins related to crambin. Biochemistry (1987) 0.79
Inhibition of tumor growth by plasminogen-related protein-B. Anticancer Res (2001) 0.78
Human plasminogen. Proton NMR studies on kringle 1. J Biol Chem (1982) 0.78
Potent bifunctional anticoagulants: Kunitz domain-tissue factor fusion proteins. Biochemistry (1997) 0.78
Analysis and identification of aromatic signals in the proton magnetic resonance spectrum of the kringle 4 fragment from human plasminogen. Biochemistry (1985) 0.78
Plasminogen kringle 4 binds the heptapeptide fragment 44-50 of the plasminogen N-terminal peptide. Blood Coagul Fibrinolysis (1995) 0.78
Computer-assisted assignment of 2D 1H NMR spectra of proteins: basic algorithms and application to phoratoxin B. J Biomol NMR (1991) 0.78
The solution conformation of the ferrichromes. II. Proton magnetic resonance of metal-free ferricrocin and ferrichrysin, conformational implications. Int J Pept Protein Res (1972) 0.78
Equilibrium and kinetic measurements of the conformational transition of thioredoxin in urea. Biochemistry (1986) 0.78
Ligand-binding effects on the kringle 4 domain from human plasminogen: a study by laser photo-CIDNP 1H-NMR spectroscopy. Biochim Biophys Acta (1989) 0.77
Proton magnetic resonance studies of barley and wheat thionins: structural homology with crambin. Biochemistry (1982) 0.77
Analysis of ligand-binding to the kringle 4 fragment from human plasminogen. Eur Biophys J (1987) 0.77
1H NMR structural characterization of a recombinant kringle 2 domain from human tissue-type plasminogen activator. Biochemistry (1989) 0.77
Human plasminogen kringle 4. Crystallization and preliminary diffraction data of two different crystal forms. J Biol Chem (1989) 0.77
1H NMR characterization of the urokinase kringle module. Structural, but not functional, relatedness to homologous domains. J Biol Chem (1993) 0.77
Solvent and temperature effects on crambin, a hydrophobic protein, as investigated by proton magnetic resonance. Eur J Biochem (1981) 0.76
Analysis of the aromatic 1H-NMR spectrum of the kringle 5 domain from human plasminogen. Evidence for a conserved kringle fold. Eur J Biochem (1988) 0.76
1H-NMR assignments and secondary structure of human plasminogen kringle 1. Eur J Biochem (1994) 0.76
1H-n.m.r. studies of the fibronectin 13 kDa collagen-binding fragment. Evidence for autonomous conserved type I and type II domain folds. Biochem J (1992) 0.75
Solvent and temperature effects on crambin, a hydrophobic protein. Biophys J (1980) 0.75
Macro- and micro-stabilities of the kringle 4 domain from plasminogen. The effect of ligand binding. Biophys J (1985) 0.75
Interspecies exchange mutagenesis of the first epidermal growth factor-like domain of human factor VII. J Thromb Haemost (2005) 0.75